Biotechnology is the use of living systems and organisms to develop or make products, or "any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use" (UN Convention on Biological Diversity, Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering, biomedical engineering, bio manufacturing, molecular engineering, etc.

Biotechnology also utilizes these products for manufacturing purpose. Some of the examples of drugs produced through biotechnology are penicillin, lincomycin, streptomucin, tylosin, peptide antibiotics, cephalosporins, etc. Modern use of similar terms includes genetic engineering as well as cell and tissue culture technologies. Biotechnology draws on the pure biological sciences and in many instances is also dependent on knowledge and methods from outside the sphere of biology. Conversely, modern biological sciences are intimately entwined and dependent on the methods developed through biotechnology and what is commonly thought of as the life sciences industry.

The present book contains process of biotechnology based bulk drugs like penicillin, B lactam antibiotics, aminoglycoside antibiotics, peptide antibiotics, anti-cancer agents, lincomycin etc. This is very resourceful book for entrepreneurs, technocrats, research scholars, libraries etc. 

Market outlook

The global medical industry is going to experience tremendous growth in the coming years with a range of development and investment opportunities for companies looking out to enter in this industry or to expand within. Healthcare industry is one of the largest sectors in the country both in terms of revenue as well as employment.

The global bulk drugs market was valued at around USD122 b in 2014 and is expected to reach USD175 b by 2019, growing at a CAGR of 7.5% during 2014–19.

India's bulk drug exports are likely to grow at a compounded annual growth rate (CAGR) of 12-14 per cent till 2018-19, driven largely by exports to regulated markets as well as continued growth in the semi-regulated markets.

Driven by exports to both regulated and semi-regulated markets, India’s bulk drug exports are likely to grow at a compound annual growth rate (CAGR) of 12–14% up to 2018–2019.

Most of this growth is expected to come from generics, with exports of bulk drugs used for manufacturing off-patent drugs expected to continue to grow at a 12–14% CAGR in the next five years till 2018–2019. Demand for active pharmaceutical ingredients from on-patent drugs, on the other hand, is expected to grow at a slower pace.

The generic drug market is expected to grow at nearly at 60 percent by the year 2016-2017 and contribute nearly 36 percent of the total market in the year 2016-2017.

The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent in 2015 from USD6 billion in 2005 and is expected to expand at a CAGR of 15.92 per cent to USD55 billion by 2020.

See more

https://goo.gl/6qPgpk

https://goo.gl/t2QFiI

https://goo.gl/zdlNLq

Contact us:

Niir Project Consultancy Services

106-E, Kamla Nagar, Opp. Spark Mall,

New Delhi-110007, India.

Email: [email protected], [email protected]

Tel: +91-11-23843955, 23845654, 23845886, 8800733955

Mobile: +91-9811043595

Website: www.entrepreneurindia.co, www.niir.org

Tags

Process for Production of Penicillin, Biotechnology in Bulk Drug Production, Manufacturing of Bulk Drugs, Bulk Drugs Production, Manufacturing Process of Penicillins, Fermentation Process, Novel Fermentation Process, Manufacture Aminoglycoside, Manufacturing Process of Tylosin, Production of Peptides, Production of Streptomycin, Fermentation Process of Cephalosporins, Cephamycin Production, Production of Lincomycin, Drug Development Process, Fermentation Process for Production of Anthracylines, Batch Fermentation Process, Fermentation Process for Production of Nucleosides, Batch Production Process, Interferon Production, Leukocyte Process, Lymphoblastoid Process, Immune Interferon Process, Production of Siderophores, Production of Cloning and Expression,  Production of Penicillin, Process of Fermentation, Production of  Fermentation, Novel Fermentation Processes for Manufacturing, Novel Fermentation Production, Manufacture of Aminoglycoside, Production of Tylosin, Manufacturing of Peptides, Production of Peptides, Process for Production of Streptomycin, Production of Cephalosporin, Fermentation for Cephalosporin Production, Production of Cephamycin, Lincomycin Production, Anthracycline Production, Process for Production of Anthracycline, Producing Nucleotide by Fermentation, Production of Nucleotides, Batch Production, Production of Interferon, Cloning And Expression of Antibiotic Production, How to Start Anthracycline Processing Industry, Production Of Cephamycin Industry, Most Profitable Novel Fermentation Production Ideas,  Cloning and Expression Processing Projects, Small Scale Nucleosides Production Projects, Starting Penicillin Production Business, How to Start Anthracylines Production Business, Bulk Drugs Based Small Scale Industries Projects, , NPCS, Niir, Process Technology Books, Business Consultancy, Business Consultant, Project Identification and Selection, Preparation of Project Profiles, Startup, Business Guidance, Business Guidance to Clients, Startup Project for Aminoglycoside Manufacture, Startup Project, Startup Ideas, Project for Startups, Startup Project Plan, Business Start-Up, Business Plan for Startup Business, Great Opportunity for Startup, Small Start-Up Business Project, Start-Up Business Plan for Peptides Production, Start Up India, Stand Up India, Modern Small and Cottage Scale Industries, Profitable Small and Cottage Scale Industries, Setting Up and Opening Your Bulk Drugs Business, How To Start Production of Nucleosides ?, Best Small and Cottage Scale Industries, Bulk Based Business, Profitable Small Scale Manufacturing